an increase of about $1.54 billion relative to the end of 2023. on the other hand, gsk's total debt/ebitda ratio has increased slightly and remains below 2x, which is also reflected in its investment-grade credit rating . source: gsk...
Emma Walmsley announces GSK's FY 2023 results 60:02 Webcast and Q&A replay for investors and analysts 31 January 2024 2023 Full year and fourth quarter We announced our full year and fourth quarter 2023 results on Wednesday 31 January. Read our cautionary statement Download full results ann...
Market Watch : GSK Expected to Show Full-Year FallJeff, Dominic
2023 5-year trend Net Income before Extraordinaries Net Income before Extraordinaries 5.27B 6.39B 3.52B 4.92B 5.31B Net Income Growth Net Income Growth - 21.26% -44.96% 39.96% 7.86% Depreciation, Depletion & Amortization Depreciation, Depletion & Amortization ...
Full-year 2023 guidance affirmed. Dividend of 14p declared for Q1 2023. 56.5p expected for the full-year 2023Q1 2023 £m % AER % CER Vaccines 2,041 22 15 Specialty Medicines 2,236 (29) (33) General Medicines 2,674 12 9 Turnover 6,951 (3) (8) Turnover excluding COVID-19 solut...
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 View the Full List Most popular news on GSK Success Every single member of the board just resigned from DNA tester 23andMe BYJane ThierSeptember 19, 2024 at 12:14 AM GMT...
Skip to main contentSkip to article
4/26/2023 Q1 2023 $0.85 $0.90 +$0.05 $0.90 $8.55 billion $8.45 billion 2/1/2023 Q4 2022 $0.59 $0.64 +$0.05 $0.36 $8.30 billion $8.66 billion Get the Latest News and Ratings for GSK and Related Stocks Enter your email address below to receive the latest news and analysts' rating...
In fiscal year 2023, the Indian arm of the pharmaceutical company GlaxoSmithKline, GSK Pharmaceutical Limited recorded a net profit of over six billion Indian rupees.
Cell Death Discovery (2023) Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics Hirohito Yamaguchi Jung-Mao Hsu Mien-Chie Hung Nature Reviews Clinical Oncology (2022) GSK3 inhibitor suppresses cell growth and metabolic process in FLT3-IT...